Foresight Health® Malignant Hyperthermia

Name: Foresight Health® Malignant Hyperthermia
Brand: The Pet Genetics Lab
SKU: CAN-S-MH
Price: 48.0 GBP
Availability: InStock

by The Pet Genetics Lab

£48.00

Quantity

Description

Description

Our Foresight Health® single test for Malignant Hyperthermia is ideal for breeders and owners who want the reassurance of genetic health testing.

The guideline turnaround time for single tests is approximately 10-12 working days after the swab arrives at the lab.

If you need more than two tests it is often more cost-effective to order the relevant Foresight Health^®breed package.

Description

Malignant Hyperthermia (MH) is a reaction whilst under general anaesthesia which causes a progressive increase in body temperature, increased heart rate, renal failure, and death.

An autosomal dominant condition caused by a mutation in the RYR1 gene.

Breeds

This test is also included in the following Foresight Health^®breed packages:

Scientific references:

Roberts MC, Mickelson JR, Patterson EE, Nelson TE, Armstrong PJ, Brunson DB, Hogan K. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology. 2001 Sep;95(3):716-25

You recently viewed

Clear recently viewed

Rated 4.7/5

Foresight Health® Malignant Hyperthermia

Description

Breeds

Related products

Foresight Health® Acral Mutilation Syndrome

The Pet Genetics Lab

Foresight Health® Alexander Disease

The Pet Genetics Lab

Foresight Health® Benign Familial Juvenile Epilepsy

The Pet Genetics Lab

Foresight Health® Canine Leucocyte Adhesion Deficiency

The Pet Genetics Lab

Foresight Health® Canine Multifocal Retinopathy

The Pet Genetics Lab

You recently viewed